Amsterdam UMC - Amsterdam institute for Immunology and Infectious Diseases

Theo Geijtenbeek and Neeltje Kootstra, immunologists at the Amsterdam institute for Immunology and Infectious diseases of Amsterdam UMC, are working on antiviral strategies to neutralize viruses before they spread. Read more about their TRIM4Health project and how it aims to prevent the next pandemic 👇 https://lnkd.in/en7UnUy6 #Immunology #Research Health~Holland QVQ Holding BV

Experts recommend a limited vaccination program for the new, more dangerous mpox variant as WHO declares it a global health risk. Prof. Henry de Vries emphasizes the need for vaccination to prevent further spread and protect vulnerable populations. Read more: https://lnkd.in/edKBTM57   #PublicHealth #Mpox #WHO #Vaccinnation  Amsterdam Public Health

📢 Join us on Tuesday, September 3, 2024, from 16:00 to 17:00 at the Sanquin Pelidome for our next AI&I Seminar on Immunology! Our keynote speaker, Dr. Bernard Malissen 🧬, will dive deep into the molecular basis of T cell malfunctions and disorders using quantitative interactomics. Dr. Malissen is renowned for his pioneering work on T cell receptor (TCR) and major histocompatibility complex (MHC) interactions, providing insights into TCR cross-reactivity and alloreactivity. His current research integrates "omic" approaches and mouse genetics to decode the complex signaling networks that drive T cell activation. Theme: Unveiling the molecular basis of T cell malfunctions and disorders using quantitative interactomics. Host: Derk Amsen 👏🏻 For more information, visit our website: https://lnkd.in/eaDqn63r We look forward to seeing you there!

🌟 TKI-PPP grant - prof. dr. Marjolein van Egmond 🌟 Prof.dr. Marjolein Van Egmond received a TKI subsidy of almost €900.000 from Health~Holland to investigate a new immunotherapeutic approach to treat cancer. Most immunotherapeutic approaches focus on engaging T cells for tumor cell killing. The van Egmond lab, however, identified neutrophils as additional cytotoxic effector cells, through targeting of the IgA Fc receptor (FcaRI; CD89) via bispecific antibodies. In this project, in collaboration with a Swiss-Amsterdam UMC spin-off company she aims to recruit both neutrophils and T cells as effector cells to improve immunotherapy of cancer. Read more: https://lnkd.in/eeNEvvdn

A recent study in Science Translational Medicine found that those who had Covid-19 are better protected against other coronaviruses. Dr. Lia Van Der Hoek from Amsterdam UMC discusses the immune response and how adding new proteins to vaccines might enhance protection.   Read more: https://lnkd.in/eP8jJVic   #COVID19 #coronavirus #infectiousdiseases #virus

🌟 Lupus Innovation Award – Dr. van Baarsen and Dr. Dankers 🌟 Dr. Lisa van Baarsen and Dr. Wendy Dankers have received the Lupus Innovation Award (LIA) by the Lupus Research Alliance ! This award funds global research for new lupus treatments and diagnostics. Dr. van Baarsen and Dr. Wendy Dankers will explore disrupted maternal-fetal tolerance in lupus. Dr. van Baarsen: ‘I am extremely honored to receive this LRA grant to push forward our translational research study on unravelling the immunological mechanism driving pregnancy complications in lupus patients. Together with my colleagues Dr. Wendy Dankers, Dr Irene Bultink and Dr. Marjon de Boer’. Congratulations! Read more: https://lnkd.in/eeNEvvdn #LupusResearch #InnovationInScience #LupusResearchAlliance

It is peak tick season, due to the mild winter and wet spring. Joppe WR Hovius, MD, PhD, professor of infectious diseases at Amsterdam UMC and director of the AI&I research institute, is involved in a large Lyme disease vaccination trial. Prof. Hovius: 'For this international study we are evaluating the vaccine among individuals with an elevated risk for Lyme disease. This includes frequent gardeners, forestry workers, and residents of high tick-bite areas'. Read more: https://lnkd.in/gCDV2xX4

The composition of the intestinal flora can predict the chances of developing serious infections such as pneumonia. Researchers from Amsterdam UMC and the Turun yliopisto - University of Turku, Finland, followed more than 10,000 people for 6 years. More than 600 people who had less healthy intestinal flora developed a serious infection, with this leading in some cases to death. The results of the study have been published in The Lancet Microbe. Read more: https://lnkd.in/eUZ5FcKH   Joost Wiersinga Bob Kullberg Amsterdam Public Health Amsterdam UMC - AGEM

A preprint by Amsterdam UMC, UMC Utrecht, Sanquin, and VU Amsterdam on BioRxiv is receiving exceptional attention, with both Science and Nature featuring news articles about it on their websites.  🧬 Discover the relationship between autoantibodies and Long COVID symptoms: https://lnkd.in/ehMh_6gf #LongCOVID #Research #autoantibodies Hung-Jen Chen Brent Appelman Amelie Bos, PhD Chiara E. Geyer Mads Delbo Larsen Eline Schüchner Marije Faulkner-Bomers Ayesha Lavell Joost Wiersinga Prof. dr. Michele van Vugt Jeroen den Dunnen

On June 7th, the annual Amsterdam UMC soccer tournament took place. The AI&I support staff assembled a team of eight players—Aram, Fenna, Leanne, Maurits, Mauro, Sait, Stella, and Tine—from various affiliated departments. They entered the tournament under the name “B cellona,” inspired by one of the greatest soccer teams and their field of research. Read more about B cellona's accomplishments during the tournament: https://lnkd.in/e8f5CPA4